Healthcare Deals This Week: 23andMe, Pfizer, Hengrui
By Yeji Jesse Lee · May 20, 2025, 8:47 PM EDT
It was a busy few days for dealmaking in the healthcare sector, with major licensing transactions from names like Pfizer and Eli Lilly and a surprise buy of once-hot genetic testing...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login